Bibliography
- An act to amend the federal food, drug, and cosmetic act to facilitate the development of drugs for rare diseases and conditions, and for other purposes. 75th United States Congress, Washington D.C; 1983. p. 97-414
- Roin B. Dormant therapies. Harvard Law School, Cambridge MA; 2014. Available from: http://petrieflom.law.harvard.edu/assets/publications/14.02.19_Roin_slides.pdf [Accessed 17 October 2014]
- The MODDERN (Modernizing Our Drug and Diagnostics Evaluation and Regulatory Network) Cures Act was introduced in the U.S. House of Representatives on November 18, 2011
- Annual updates and notifications of changes. Available from: http://www.ema.europa.eu/ema/ [Accessed 9 October 2014]
- Wolfe E, Clancy C, Jasper G, et al. Science Power 9: Atlantic Canada Edition. McGraw-Hill Ryerson Ltd; Toronto: 2000
- Dagoon JD. Applied nutrition and food technology. REX Printing Co. Ltd; Quezon City PH: 1989
- Taylor DW. History, evidence and reason: a review of proposals for and innovative sources of funding to stimulate R&D. The Cameron Institute; Hamilton ON: 2009
- The MODDERN (Modernizing Our Drug and Diagnostics Evaluation and Regulatory Network) Cures Act
- Rare diseases. Available from: http://www.siope.eu/activities/european-advocacy/rare-diseases/ [Accessed 16 October 2014]
- Rare Diseases: facts and statistics. Available from: http://globalgenes.org/rare-diseases-facts-statistics/ [Accessed 16 October 2014]